~~<i id='841F088675'><strike id='841F088675'><tt id='841F088675'><pre id='841F088675'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

explore

author：hotspot 2025-09-30 17:27:05 - browse：28

Blue nerve cell surrounded by red antibodies. -- health coverage from STAT — Adobe

Belgian drugmaker Argenx said Monday that its antibody treatment called Vyvgart significantly delayed the progression of an autoimmune nerve disorder that causes people to lose feeling and muscle strength in the arms and legs.

The positive outcome — a 61% reduction in the risk of relapse compared to a placebo — achieved the main goal of a Phase 3 clinical trial designed to demonstrate Vyvgart’s benefit for patients with chronic inflammatory demyelinating polyneuropathy, or CIDP.

“We hit the bullseye,” said Argenx CEO Tim Van Hauwermeiren.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Eli Lilly CEO gives to Mike Pence presidential super PAC

hotspot

knowledge

focus

leisure time

AfterHurricaneMaria,mostresidentsofruralPuertoRicowerewithoutelectricityandcutofffromhealthcare.InMo

WSS

Primary care doctor shortage won't be solved by free med school tuition

Primary care doctor shortage won't be solved by free med school tuition

Akili changes sales model for its ADHD video game treatment

Class action alleges UnitedHealth concealed DOJ probe

PBM executives asked to testify by House panel

People with substance use disorder deserve online privacy

Wikipedia

explore

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

FDA panel to weigh safety of artificial wombs for preterm births

Novavax promises a turnaround & Lilly roils the obesity market

AI for drug discovery: Experts on separating hype from reality

United colonoscopy coverage change 'may cost lives,' doctors say

Assistant physicians can help address the primary care shortage

Drug repurposing or repositioning? The language matters

People with substance use disorder deserve online privacy

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The unintended consequences of overturning Roe v. Wade

knowledge

Empower primary care with adequate payments and technology

Assistant physicians can help address the primary care shortage

White House Covid adviser calls on docs to combat misinformation

Fed up with FDA, ALS advocates consider a take

Fed up with FDA, ALS advocates consider a take

'A game

focus

focus

focus

leisure time